ReShape Lifesciences Inc (NASDAQ:RSLS)’s traded shares stood at 188.39 million during the last session, with the company’s beta value hitting 1.47. At the close of trading, the stock’s price was $0.57, to imply an increase of 65.58% or $0.23 in intraday trading. The RSLS share’s 52-week high remains $29.00, putting it -4987.72% down since that peak but still an impressive 47.37% since price per share fell to its 52-week low of $0.30. The company has a valuation of $6.39M, with an average of 70.71 million shares in intraday trading volume over the past 10 days and average of 9.52 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for ReShape Lifesciences Inc (RSLS), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give RSLS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
ReShape Lifesciences Inc (NASDAQ:RSLS) trade information
After registering a 65.58% upside in the last session, ReShape Lifesciences Inc (RSLS) has traded red over the past five days. The 5-day price performance for the stock is 49.22%, and -15.45% over 30 days. With these gigs, the year-to-date price performance is -87.30%. Short interest in ReShape Lifesciences Inc (NASDAQ:RSLS) saw shorts transact 0.37 million shares and set a 0.11 days time to cover.
RSLS Dividends
ReShape Lifesciences Inc has its next earnings report out on 2024-Nov-13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
ReShape Lifesciences Inc (NASDAQ:RSLS)’s Major holders
ReShape Lifesciences Inc insiders hold 14.01% of total outstanding shares, with institutional holders owning 16.64% of the shares at 19.35% float percentage. In total, 16.64% institutions holds shares in the company.
We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the ReShape Lifesciences Inc (RSLS) shares. Going by data provided on Feb 28, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 2.39 shares. This is just over 0.02% of the total shares, with a market valuation of $1355.0. Data from the same date shows that the other fund manager holds a little less at 860.0, or 0.01% of the shares, all valued at about 487.0.
